Home › Funds › Palo Alto Investors LP › DYN

Palo Alto Investors LP position in DYN

DYNE THERAPEUTICS INC · Health Care

Palo Alto Investors LP reported holding 1,881,927 shares of DYN (DYNE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$30.3M, representing 4.51% of its reported portfolio and ranking #8 among its reported holdings. Palo Alto Investors LP has disclosed DYN holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)1.88M sh
Reported value held$30.32M
Portfolio Weight4.51%
First reportedQ1 2025
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Palo Alto Investors LP's DYN position evolved

Palo Alto Investors LP first disclosed a stake in DYN in Q1 2025 at 333,391 shares (US$3.5M). The position peaked in Q2 2026 at 1,647,521 shares, worth US$36.6M. Across 7 filings, Palo Alto Investors LP increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,881,927 shares valued at US$30.3M — an increase of 234,406 shares quarter over quarter.. Notable position changes include a 377% increase in Q3 2025 (shares rose 55% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 333.39K $3.49M New
Q2 2025 264.98K $2.52M Reduce
Q3 2025 1.26M $15.97M Add
Q4 2025 1.47M $28.80M Add
Q1 2026 1.65M $29.97M Add
Q2 2026 1.65M $36.59M Hold
Q3 2026 1.88M $30.32M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DYN and 13F data

DYN (DYNE THERAPEUTICS INC) is a Health Care company. 33 other funds we track also report a position in DYN — the largest reported positions include Vestal Point Capital, LP (US$99.9M), TCG Crossover Management, LLC (US$74.3M), Frazier Life Sciences Management, L.P. (US$62.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DYN

All DYN fund holders →

FAQ

How long has Palo Alto Investors LP held DYN?

Palo Alto Investors LP has disclosed DYN holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Palo Alto Investors LP's current position in DYN?

As of Q3 2026, Palo Alto Investors LP holds 1.88M shares of DYN (DYNE THERAPEUTICS INC), valued at $30.32M, representing 4.51% of its reported portfolio and ranking #8.

Has Palo Alto Investors LP been buying or selling DYN?

In the latest 13F filing (Q3 2026), Palo Alto Investors LP increased its position in DYN. The position peaked in Q2 2026 at 1.65M shares.

Which other funds hold DYN?

Other major institutional holders of DYN include Vestal Point Capital, LP, TCG Crossover Management, LLC, Frazier Life Sciences Management, L.P., among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.